ACM
ADAR1 Capital Management Portfolio holdings
AUM
$616M
1-Year Return
26.77%
This Quarter Return
+12.77%
1 Year Return
+26.77%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$616M
AUM Growth
+$96.2M
(+19%)
Cap. Flow
+$63.3M
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
49.49%
Holding
239
New
40
Increased
63
Reduced
54
Closed
33
Top Buys
| 1 |
Keros Therapeutics
KROS
|
$52.1M |
| 2 |
Prothena Corp
PRTA
|
$20.5M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$14M |
| 4 |
CytomX Therapeutics
CTMX
|
$6.89M |
| 5 |
ABVX
Abivax
ABVX
|
$6.59M |
Top Sells
| 1 |
Roivant Sciences
ROIV
|
$17.4M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$8.63M |
| 3 |
Immunovant
IMVT
|
$6.94M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$6.34M |
| 5 |
AVR
Anteris Technologies Global Corp. Common Stock
AVR
|
$4.35M |
Sector Composition
| 1 | Healthcare | 83.61% |
| 2 | Financials | 2.95% |
| 3 | Consumer Discretionary | 0% |
| 4 | Utilities | 0% |
